This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Yuhan Corporation. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Gyu-Jin Lee: Innovator in Pharmaceutical Chemistry
Introduction
Gyu-Jin Lee is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on compounds that can impact cholesterol metabolism.
Latest Patents
One of Gyu-Jin Lee's key patents is for a 4,5-dihydro-1H-pyrazole derivative or its pharmaceutically acceptable salt. This invention also includes a pharmaceutical composition comprising the same. The 4,5-dihydro-1H-pyrazole derivative effectively increases the LXR transcriptional activity, making it a promising candidate for preventing or treating dysfunctions in cholesterol metabolism, such as cholesterol gallstone, hyperlipidemia, or coronary atherosclerosis. He holds 1 patent related to this innovative compound.
Career Highlights
Gyu-Jin Lee is associated with Yuhan Corporation, a leading pharmaceutical company in South Korea. His work at Yuhan Corporation has allowed him to focus on developing new therapeutic solutions that address critical health issues.
Collaborations
He has collaborated with notable colleagues, including Hee-Jae Tak and Koo-Yeon Lee, to advance research and development in the pharmaceutical sector.
Conclusion
Gyu-Jin Lee's contributions to pharmaceutical chemistry, particularly through his patented inventions, highlight his role as an innovator in the field. His work continues to pave the way for advancements in treatments for cholesterol-related health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile